ID   MED1
AC   CVCL_IR47
SY   nMED1
DR   Wikidata; Q54930834
RX   PubMed=20978004;
RX   PubMed=24887326;
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C129446; Medulloblastoma, non-WNT/non-SHH, group 4
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y5M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
RX   PubMed=20978004; DOI=10.1093/neuonc/noq144; PMCID=PMC3018909;
RA   Hussein D., Punjaruk W., Storer L.C.D., Shaw L., Othman R.T., Peet A.C.,
RA   Miller S., Bandopadhyay G., Heath R., Kumari R., Bowman K.J.,
RA   Braker P., Rahman R., Jones G.D.D., Watson S.A., Lowe J.S., Kerr I.D.,
RA   Grundy R.G., Coyle B.;
RT   "Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA
RT   repair, and etoposide extrusion.";
RL   Neuro-oncol. 13:70-83(2011).
//
RX   PubMed=24887326; DOI=10.1186/2051-5960-2-57; PMCID=PMC4229867;
RA   Othman R.T., Kimishi I., Bradshaw T.D., Storer L.C.D., Korshunov A.,
RA   Pfister S.M., Grundy R.G., Kerr I.D., Coyle B.;
RT   "Overcoming multiple drug resistance mechanisms in medulloblastoma.";
RL   Acta Neuropathol. Commun. 2:57.1-57.14(2014).
//